ArticleItalian journal of pediatrics2025
Bronchoalveolar lavage cytokine profile and clinical features as risk predictors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Early Risk Stratification for Subsequent Small Airway Dysfunction in Hospitalized Children withChildren (Basel, Switzerland) · 2026Article
- Network analysis of Mycoplasma pneumoniae pneumonia and Epstein-Barr virus co-infection.BMC infectious diseases · 2026Article
- Analysis of the pathogens and clinical characteristics of pediatric necrotizing pneumonia patients in a tertiary grade a hospital from 2019 to 2025: a retrospective study design.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Identification of human exposure to airborne micro-plastics and its potential effects utilizing bronchoalveolar lavage (BAL) fluid.Bioinformation · 2026Article
- Development and validation of a nomogram for predicting recurrent plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.Frontiers in pediatrics · 2026Article
- A fever-based therapeutic window for bronchoscopy to prevent bronchiolitis obliterans in children with Mycoplasma pneumoniae pneumonia.Frontiers in pediatrics · 2026Article
- Early prediction of plastic bronchitis in pediatric patients withFrontiers in cellular and infection microbiology · 2026Article
- Identification of clinical phenotypes and prediction model for the mixed-infection phenotype of pediatric community-acquired pneumonia based on unsupervised machine learning.Frontiers in pediatrics · 2026Article
- Clinical risk factors and a predictive nomogram for mechanical ventilation in pediatric patients with infection-related plastic bronchitis.BMC infectious diseases · 2025Article
- Immune activation and mucin dysregulation in pediatric refractoryFrontiers in cellular and infection microbiology · 2025Article
- Risk factors for multiple bronchoalveolar lavage procedures in children with severe or refractory Mycoplasma pneumoniae pneumonia.Jornal de pediatriaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlastic bronchitis (PB), a condition in which mucus plugs block the bronchial tree, is a serious complication of Mycoplasma pneumoniae pneumonia (MPP). This study investigated whether clinical features and cytokine levels in bronchoalveolar lavage fluid (BALF) distinguish MPP from MPP complicated by PB and sought to identify risk factors for PB in children with MPP.
methodsA total of 128 children 3-14 years of age with MPP who underwent bronchoscopy at Jingmen Central Hospital, China, between 1 April 2023 and 31 March 2024 were enrolled. Patients were divided into a PB and a non-PB group based on bronchoscopy findings. Clinical manifestations and laboratory findings, including BALF cytokine levels, were compared. A risk prediction nomogram for PB was constructed and evaluated.
resultsOf 128 children with MPP, 40 (31%) had PB. Multivariate logistic regression analysis showed that clinically severe MPP (OR = 8.78; P = 0.002), systemic inflammatory response syndrome (SIRS) (OR = 2.78; P = 0.049) and elevated BALF interleukin-6 (IL-6) (OR = 1.01; P < 0.001) were independent risk factors for PB. The area under the receiver operating characteristic (ROC) curve (AUC) value for the combination of severe MPP, SIRS and IL-6 was 0.852 (95% confidence interval, 0.77-0.93). A calibration curve showed good agreement between nomogram prediction and actual observations (P = 0.723). A decision curve analysis indicated that the nomogram demonstrated good clinical applicability.
conclusionPronounced inflammatory responses and increased clinical severity of MPP are associated with PB. A nomogram that integrates clinical features and BALF IL-6 levels may be used for risk assessment and management of PB in MPP after initial bronchoscopy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.